Shownotes
Professor Elia Ferracuti explains how activist investors reshape corporate research, and why it matters for long-term innovation. Why would a company famous for breakthrough discoveries suddenly pull back from bold research in favor of safer bets? Research shows shareholder pressure plays a role. The tension between short-term financial pressure and long-term scientific progress is at the heart of many hedge-fund-led activist campaigns and may explain why companies retreat from basic research...

